Press Releases

Showing 1–10 of 18 posts

Press Releases
05.01.24

Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems
Press Releases
04.08.24

Metagenomi to Present at Upcoming Scientific Meetings
Press Releases
03.27.24

Metagenomi Reports Business Updates and Full Year 2023 Financial Results
Press Releases
02.29.24

Metagenomi to Participate in the 44th Annual Cowen Healthcare Conference
Press Releases
02.13.24

Metagenomi Announces Closing of Initial Public Offering
Press Releases
02.08.24

Metagenomi Announces Pricing of Initial Public Offering
Press Releases
11.09.23

Metagenomi Appoints Luis Borges, Ph.D., as Chief Scientific Officer and Pamela Wapnick, MBA, as Chief Financial Officer
Press Releases
05.19.23

Metagenomi Presents New Data on Novel Gene Editing Systems at the 26th American Society of Gene + Cell Therapy (ASGCT) Annual Meeting
Press Releases
05.02.23

Metagenomi to Present New Data for Its Novel Gene-Editing Systems at the 26th American Society of Gene + Cell Therapy (ASGCT) Annual Meeting
Press Releases
03.06.23

Metagenomi Announces Participation in March Investor Conferences